FDA Drug Recalls

Recalls / Class II

Class IID-0606-2022

Product

Severe Congestion No Drip Nasal Spray Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY DOLGENCORP, LLC, 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072. NDC 55910-511-10

Brand name
Dg Health Nasal
Generic name
Oxymetazoline Hydrochloride
Active ingredient
Oxymetazoline Hydrochloride
Route
Nasal
NDC
55910-511
FDA application
M012
Affected lot / code info
Batch: 1BK0716, Exp 12/31/2022); 1CK0899, Exp 01/31/2023; 1FK1163, Exp 01/31/2023

Why it was recalled

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Recalling firm

Firm
Perrigo Company PLC
Manufacturer
Dolgencorp, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, Allegan, Michigan 49010-9070

Distribution

Quantity
21,4824 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-10-26
FDA classified
2022-02-23
Posted by FDA
2022-03-02
Terminated
2023-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0606-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.